John G. Houston, Ph.D.

President and Chief Executive Officer

Sharvari Apte

Vice President of Global and US Commercial Analytics

Matthew Batters, J.D.

General Counsel and Corporate Secretary

Jeff Boyle

Vice President of Investor Relations

Angela M. Cacace, Ph.D.

Senior Vice President, Neuroscience and Platform Biology

Sean Cassidy, C.P.A.

Chief Financial Officer

Debbie Chirnomas, M.D., M.P.H.

Vice President of Oncology Clinical Research

John A. Grosso, Ph.D.

Senior Vice President, R&D Technical Operations

Janice Kapty, Ph.D.

Vice President, Estrogen Receptor Global Asset Lead

Kelly Page

Senior Vice President, Global Head of Oncology Strategy and Program Leadership

Eric Masson, PharmD

Vice President, Early Clinical Development

Paul McInulty

Senior Vice President, Regulatory Affairs

John Northcott

Chief Commercial Officer

Achal Pashine, M.Sc. Ph.D.

Vice President of Oncology and Immuno-Oncology Research

Ron Peck, M.D.

Chief Medical Officer

Julie Rudnicki, Ph.D

Vice President, Global Androgen Receptor Degrader Assets Program Leader

Alex Santini

Senior Vice President of Global and U.S. Market Access

Shiva Sekhar

Vice President of Global and U.S. Marketing for Breast Cancer

Christina Sheil, M.D.

Vice President, Pharmacovigilance 

Lisa Sinclair

Senior Vice President, Corporate Operations

Larry Snyder, Ph.D.

Vice President of Medicinal Chemistry

Ian Taylor, Ph.D.

Chief Scientific Officer

Randy Teel, Ph.D.

Senior Vice President, Corporate and Business Development

Kimberly Wehger

Vice President, Information Technology and Corporate Projects

Steve Weiss

Senior Vice President, Chief Human Resources Officer